PamGene

Biotechnology, Clinical Trials, Therapeutics
Founded in 1/1/00
's-hertogenbosch, Noord-Brabant, The Netherlands
http://www.pamgene.com/
For Profit

About PamGene

PamGene has a unique proprietary array-based platform to measure the activities of kinases & nuclear receptors, enabling deeper understanding of drug interactions with these important classes of signalling molecules. PamGene's patented technology finds a wide range of applications including lead identification and optimization, (pre) clinical translational research and biomarker development.

Company Metrics

  • Employees: 11-50
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue: $1M to $10M
  • Total Funding: 19700000 EUR
  • Last Funding: 1000000 EUR (Grant)
  • Funding Status: Early Stage Venture

Technology Stack

PamGene actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology, Clinical Trials, Therapeutics

Headquarters: 's-hertogenbosch, Noord-Brabant, The Netherlands